Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0646 CHF | +2.54% | +19.19% | +57.56% |
01/05 | SIX Swiss Exchange Approves Delay in Spexis' FY23 Annual Report Publication | MT |
17/04 | Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis | MT |
- Stock Market
- Equities
- POLN Stock
- News Spexis AG
- MarketScreener Strategies